
Serum KL-6 as a Diagnostic Biomarker in ... - Pulmonology Advisor
2022年2月8日 · Although serum KL-6 is a stable biomarker that is not affected by lung infection and smoking status, those in the IPF arm with antinuclear antibodies demonstrated higher KL …
Biomarkers Predictive of Systemic Sclerosis-Interstitial Lung …
2019年1月30日 · Other predictive markers include chemokine (C-C motif) ligand 18 (CCL18) for progression of ILD and Krebs von den Lungen-6 (KL-6) for acuteness of lung fibrosis. The 2 …
Reliable Biomarkers Identified for Diagnosing Systemic Sclerosis …
2022年12月7日 · Potential soluble biomarkers in peripheral blood/bronchoalveolar lavage fluid (BALF) for the diagnosis of systemic sclerosis interstitial lung disease (SSc-ILD) include Krebs …
Biomarker Index Can Identify ILD in Patients With Systemic Sclerosis
2023年4月13日 · “Ca15-3 may be a lower-cost, more accessible surrogate for KL-6 in future biomarker assessment.” Disclosure: Research grants for this study were received from …
Unsuccessful Treatment Outcomes in Nontuberculous …
2020年4月16日 · With a median follow-up of 31 months, adverse events were reported in 37.6% of the participants. Considering the study population as a whole, treatment outcomes included …
Veterans’ Health: The Link Between Blast Exposure and Respiratory ...
2022年9月20日 · Veterans reporting blast exposure were more likely to experience respiratory symptoms, including cough, dyspnea, and wheezing, as well as an aggregate assessment of …
Influenza May Increase Risk for Acute Myocardial Infarction
2018年1月29日 · The incidence ratio was 6.05 for admission for acute MI during the risk interval vs the control interval. After day 7 there was no increased incidence. The incidence ratios …
FDA Drug Approval Decisions Expected in April 2025
5 天之前 · The typical period for review is 10 months after the drug application has been accepted by the Agency. For drugs that have Priority Review, the review period is reduced to 6 months …
Methimazole Effective Substitution for Propylthiouracil in Patients ...
2023年5月22日 · A sensitivity analysis of 2845 patients using full optimal matching showed no significant between-group differences in the occurrence of in-hospital death or discharge to …
The Limits of Antimicrobial Sensitivity Testing in Cystic Fibrosis
2019年7月30日 · 5. Aaron SD, Vandemheen KL, Ferris W, et al. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant …